Patents by Inventor Matthew Colin Thor Fyee

Matthew Colin Thor Fyee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE
    Publication number: 20180127406
    Abstract: The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Thus, in one specific aspect the invention relates to formulas (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
    Type: Application
    Filed: June 15, 2017
    Publication date: May 10, 2018
    Inventors: Alberto ORTEGA MUÑOZ, Matthew Colin Thor FYEE, Marc MARTINELL PEDEMONTE, Iñigo TIRAPU FERNANDEZ DE LA CUESTA, Maria de los Ángeles ESTIARTE MARTINEZ
  • USE OF GPCR AGONISTS TO DELAY PROGRESSION OF DIABETES
    Publication number: 20090258816
    Abstract: The present invention is directed to the use of G-protein coupled receptor agonists for the treatment of beta-cell degeneration.
    Type: Application
    Filed: June 1, 2007
    Publication date: October 15, 2009
    Inventors: Matthew Colin Thor Fyee, Peter Widdowson